Skip to main content
SpringerLink
Log in

Recent Developments in the Diagnosis and Management of Photosensitive Disorders

  • Review Article
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

Photodermatoses occur in males and females of all races and ages. Onset can be variable in timing and influenced by genetic and environmental factors. Photodermatoses are broadly classified as immunologically mediated, chemical- and drug-induced, photoaggravated, and genetic (defective DNA repair or chromosomal instability) diseases. Advances in the field have led to improved recognition and treatment of many photodermatoses. The purpose of this focused review is to provide an update on the diagnosis and management of a variety of photodermatoses, both common and less common, with review of recent updates in the literature pertaining to their diagnosis and management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Courtesy of Martha Valbuena, MD, Bogota, Columbia

Fig. 3

Courtesy of Tor Shwayder, MD, Detroit, MI, USA

Fig. 4
Fig. 5
Fig. 6
Fig. 7

Courtesy of Tor Shwayder, MD, Detroit, MI, USA

Similar content being viewed by others

References

  1. Lim H, Hawk JLM, Rosen C. Photodermatoses. In: Bolognia J, Schaffer JV, Cerroni L, editors. Dermatology. 4th ed. London: Elsevier; 2018. p. 1548–68.

    Google Scholar 

  2. Oakley A, James WD. Photosensitivity. StatPearls. Treasure Island: StatPearls Publishing LLC; 2017.

    Google Scholar 

  3. Oakley A, Ramsey ML. Polymorphic light eruption StatPearls. Treasure Island: StatPearls Publishing LLC; 2017.

    Google Scholar 

  4. Wolf P, Byrne SN, Gruber-Wackernagel A. New insights into the mechanisms of polymorphic light eruption: resistance to ultraviolet radiation-induced immune suppression as an aetiological factor. Exp Dermatol. 2009;18(4):350–6.

    Article  PubMed  CAS  Google Scholar 

  5. Pao C, Norris PG, Corbett M, Hawk JL. Polymorphic light eruption: prevalence in Australia and England. Br J Dermatol. 1994;130(1):62–4.

    Article  PubMed  CAS  Google Scholar 

  6. Gruber-Wackernagel A, Byrne SN, Wolf P. Polymorphous light eruption: clinic aspects and pathogenesis. Dermatol Clin. 2014;32(3):315–34 (viii).

    Article  PubMed  CAS  Google Scholar 

  7. Stratigos AJ, Antoniou C, Katsambas AD. Polymorphous light eruption. J Eur Acad Dermatol Venereol. 2002;16(3):193–206.

    Article  PubMed  CAS  Google Scholar 

  8. Rhodes LE, Bock M, Janssens AS, Ling TC, Anastasopoulou L, Antoniou C, et al. Polymorphic light eruption occurs in 18% of Europeans and does not show higher prevalence with increasing latitude: multicenter survey of 6895 individuals residing from the Mediterranean to Scandinavia. J Investig Dermatol. 2010;130(2):626–8.

    Article  PubMed  CAS  Google Scholar 

  9. Epstein JH. Polymorphous light eruption. Photodermatol Photoimmunol Photomed. 1997;13(3):89–90.

    Article  PubMed  CAS  Google Scholar 

  10. Epstein S. Studies in abnormal human sensitivity to light: IV. Photoallergic concept of prurigo aestivalis. J Investig Dermatol. 1942;5(6):289–98.

    Article  Google Scholar 

  11. Watanabe M, Yamanouchi H, Ogawa F, Katayama I. Polymorphous light eruption. A case report and consideration of the hardening mechanism. Dermatology. 1999;199(2):158–61.

    Article  PubMed  CAS  Google Scholar 

  12. Gonzalez-Amaro R, Baranda L, Salazar-Gonzalez JF, Abud-Mendoza C, Moncada B. Immune sensitization against epidermal antigens in polymorphous light eruption. J Am Acad Dermatol. 1991;24(1):70–3.

    Article  PubMed  CAS  Google Scholar 

  13. Fukunaga A, Khaskhely NM, Ma Y, Sreevidya CS, Taguchi K, Nishigori C, et al. Langerhans cells serve as immunoregulatory cells by activating NKT cells. J Immunol (Baltimore, Md: 1950). 2010;185(8):4633–40.

    Article  CAS  Google Scholar 

  14. Hadshiew IM, Treder-Conrad C, Bulow RV, Klette E, Mann T, Stab F, et al. Polymorphous light eruption (PLE) and a new potent antioxidant and UVA-protective formulation as prophylaxis. Photodermatol Photoimmunol Photomed. 2004;20(4):200–4.

    Article  PubMed  CAS  Google Scholar 

  15. Krutmann J, Grewe M. Involvement of cytokines, DNA damage, and reactive oxygen intermediates in ultraviolet radiation-induced modulation of intercellular adhesion molecule-1 expression. J Investig Dermatol. 1995;105(1 Suppl):67s–70s.

    Article  PubMed  CAS  Google Scholar 

  16. Grether-Beck S, Olaizola-Horn S, Schmitt H, Grewe M, Jahnke A, Johnson JP, et al. Activation of transcription factor AP-2 mediates UVA radiation- and singlet oxygen-induced expression of the human intercellular adhesion molecule 1 gene. Proc Natl Acad Sci USA. 1996;93(25):14586–91.

    Article  PubMed  CAS  Google Scholar 

  17. Millard TP, Fryer AA, McGregor JM. A protective effect of glutathione-S-transferase GSTP1*Val(105) against polymorphic light eruption. J Investig Dermatol. 2008;128(8):1901–5.

    Article  PubMed  CAS  Google Scholar 

  18. Zirbs M, Purner C, Buters JT, Effner R, Weidinger S, Ring J, et al. GSTM1, GSTT1 and GSTP1 gene polymorphism in polymorphous light eruption. J Eur Acad Dermatol Venereol. 2013;27(2):157–62.

    Article  PubMed  CAS  Google Scholar 

  19. McGregor JM, Grabczynska S, Vaughan R, Hawk JL, Lewis CM. Genetic modeling of abnormal photosensitivity in families with polymorphic light eruption and actinic prurigo. J Investig Dermatol. 2000;115(3):471–6.

    Article  PubMed  CAS  Google Scholar 

  20. Millard TP, Bataille V, Snieder H, Spector TD, McGregor JM. The heritability of polymorphic light eruption. J Investig Dermatol. 2000;115(3):467–70.

    Article  PubMed  CAS  Google Scholar 

  21. Elpern DJ, Morison WL, Hood AF. Papulovesicular light eruption. A defined subset of polymorphous light eruption. Arch Dermatol. 1985;121(10):1286–8.

    Article  PubMed  CAS  Google Scholar 

  22. Isedeh P, Lim HW. Polymorphous light eruption presenting as pinhead papular eruption on the face. J Drugs Dermatol. 2013;12(11):1285–6.

    PubMed  Google Scholar 

  23. Aljasser MI, Lui H, Ball NJ, Kalia S. Persistent polymorphous light eruption after ultraviolet al phototherapy. Photodermatol Photoimmunol Photomed. 2013;29(1):52–4.

    Article  PubMed  Google Scholar 

  24. Stratigos AJ, Antoniou C, Papadakis P, Papapostolou A, Sabatziotis D, Tranaka K, et al. Juvenile spring eruption: clinicopathologic features and phototesting results in 4 cases. J Am Acad Dermatol. 2004;50(2 Suppl):S57–60.

    Article  PubMed  Google Scholar 

  25. Lava SA, Simonetti GD, Ragazzi M, Guarino Gubler S, Bianchetti MG. Juvenile spring eruption: an outbreak report and systematic review of the literature. Br J Dermatol. 2013;168(5):1066–72.

    Article  PubMed  CAS  Google Scholar 

  26. Wolf P, Soyer HP, Fink-Puches R, Huff JC, Kerl H. Recurrent post-herpetic erythema multiforme mimicking polymorphic light and juvenile spring eruption: report of two cases in young boys. Br J Dermatol. 1994;131(3):364–7.

    Article  PubMed  CAS  Google Scholar 

  27. Norris PG, Hawk JL. Polymorphic light eruption. Photodermatol Photoimmunol Photomed. 1990;7(5):186–91.

    PubMed  CAS  Google Scholar 

  28. Wolf R, Oumeish OY. Photodermatoses. Clin Dermatol. 1998;16(1):41–57.

    Article  PubMed  CAS  Google Scholar 

  29. Ferguson J, Ibbotson S. The idiopathic photodermatoses. Semin Cutan Med Surg. 1999;18(4):257–73.

    Article  PubMed  CAS  Google Scholar 

  30. Janssens AS, Pavel S, Out-Luiting JJ, Willemze R, de Gruijl FR. Normalized ultraviolet (UV) induction of Langerhans cell depletion and neutrophil infiltrates after artificial UVB hardening of patients with polymorphic light eruption. Br J Dermatol. 2005;152(6):1268–74.

    Article  PubMed  CAS  Google Scholar 

  31. Wolf P, Gruber-Wackernagel A, Bambach I, Schmidbauer U, Mayer G, Absenger M, et al. Photohardening of polymorphic light eruption patients decreases baseline epidermal Langerhans cell density while increasing mast cell numbers in the papillary dermis. Exp Dermatol. 2014;23(6):428–30.

    Article  PubMed  CAS  Google Scholar 

  32. Yashar SS, Lim HW. Classification and evaluation of photodermatoses. Dermatol Ther. 2003;16(1):1–7.

    Article  PubMed  Google Scholar 

  33. Bylaite M, Grigaitiene J, Lapinskaite GS. Photodermatoses: classification, evaluation and management. Br J Dermatol. 2009;161(Suppl 3):61–8.

    Article  PubMed  CAS  Google Scholar 

  34. Man I, Dawe RS, Ferguson J. Artificial hardening for polymorphic light eruption: practical points from 10 years’ experience. Photodermatol Photoimmunol Photomed. 1999;15(3–4):96–9.

    Article  PubMed  CAS  Google Scholar 

  35. Corbett MF, Hawk JL, Herxheimer A, Magnus IA. Controlled therapeutic trials in polymorphic light eruption. Br J Dermatol. 1982;107(5):571–81.

    Article  PubMed  CAS  Google Scholar 

  36. Murphy GM, Hawk JL, Magnus IA. Hydroxychloroquine in polymorphic light eruption: a controlled trial with drug and visual sensitivity monitoring. Br J Dermatol. 1987;116(3):379–86.

    Article  PubMed  CAS  Google Scholar 

  37. Norris PG, Hawk JL. Successful treatment of severe polymorphous light eruption with azathioprine. Arch Dermatol. 1989;125(10):1377–9.

    Article  PubMed  CAS  Google Scholar 

  38. Shipley DR, Hewitt JB. Polymorphic light eruption treated with cyclosporin. Br J Dermatol. 2001;144(2):446–7.

    Article  PubMed  CAS  Google Scholar 

  39. Tanew A, Radakovic S, Gonzalez S, Venturini M, Calzavara-Pinton P. Oral administration of a hydrophilic extract of Polypodium leucotomos for the prevention of polymorphic light eruption. J Am Acad Dermatol. 2012;66(1):58–62.

    Article  PubMed  Google Scholar 

  40. Caccialanza M, Percivalle S, Piccinno R, Brambilla R. Photoprotective activity of oral Polypodium leucotomos extract in 25 patients with idiopathic photodermatoses. Photodermatol Photoimmunol Photomed. 2007;23(1):46–7.

    Article  PubMed  CAS  Google Scholar 

  41. Valbuena MC, Muvdi S, Lim HW. Actinic prurigo. Dermatol Clin. 2014;32(3):335–44 (viii).

    Article  PubMed  CAS  Google Scholar 

  42. Lane PR, Hogan DJ, Martel MJ, Reeder B, Irvine J. Actinic prurigo: clinical features and prognosis. J Am Acad Dermatol. 1992;26(5 Pt 1):683–92.

    Article  PubMed  CAS  Google Scholar 

  43. Hojyo-Tomoka T, Vega-Memije E, Granados J, Flores O, Cortes-Franco R, Teixeira F, et al. Actinic prurigo: an update. Int J Dermatol. 1995;34(6):380–4.

    Article  PubMed  CAS  Google Scholar 

  44. Vega Memije ME, Cuevas Gonzalez JC, Hojyo-Tomoka MT, Rodriguez Lobato E. Actinic prurigo as a hypersensitivity reaction type 4. Int J Dermatol. 2017;56(6):e135–6.

    Article  PubMed  Google Scholar 

  45. Hönigsmann H, Hojyo-Tomoka MT. Polymorphous light eruption, hydroa vacciniforme, and actinic prurigo. In: Lim H, Hönigsmann H, Hawk J, editors. Photodermatology. New York: Informa Healthcare; 2007. p. 149–68.

    Google Scholar 

  46. Menage Hd, Vaughan RW, Baker CS, Page G, Proby CM, Breathnach SM, et al. HLA-DR4 may determine expression of actinic prurigo in British patients. J Investig Dermatol. 1996;106(2):362–7.

    Article  Google Scholar 

  47. Dawe RS, Collins P, Ferguson J, O’Sullivan A. Actinic prurigo and HLA-DR4. J Investig Dermatol. 1997;108(2):233–4.

    Article  PubMed  CAS  Google Scholar 

  48. Hojyo-Tomoka T, Granados J, Vargas-Alarcon G, Yamamoto-Furusho JK, Vega-Memije E, Cortes-Franco R, et al. Further evidence of the role of HLA-DR4 in the genetic susceptibility to actinic prurigo. J Am Acad Dermatol. 1997;36(6 Pt 1):935–7.

    Article  PubMed  CAS  Google Scholar 

  49. Ross JB. HLA typing in polymorphic light eruption. J Am Acad Dermatol. 1992;26(4):658–9.

    Article  PubMed  CAS  Google Scholar 

  50. Sheridan DP, Lane PR, Irvine J, Martel MJ, Hogan DJ. HLA typing in actinic prurigo. J Am Acad Dermatol. 1990;22(6 Pt 1):1019–23.

    Article  PubMed  CAS  Google Scholar 

  51. Bernal JE, Duran de Rueda MM, Ordonez CP, Duran C, de Brigard D. Actinic prurigo among the Chimila Indians in Colombia: HLA studies. J Am Acad Dermatol. 1990;22(6 Pt 1):1049–51.

    Article  PubMed  CAS  Google Scholar 

  52. Bernal JE, Duran de Rueda MM, de Brigard D. Human lymphocyte antigen in actinic prurigo. J Am Acad Dermatol. 1988;18(2 Pt 1):310–2.

    PubMed  CAS  Google Scholar 

  53. Grabczynska SA, Carey BS, McGregor JM, Hawk JL, Vaughan RW. Tumour necrosis factor alpha promoter polymorphism at position − 308 is not associated with actinic prurigo. Clin Exp Dermatol. 2001;26(8):700–4.

    Article  PubMed  CAS  Google Scholar 

  54. Ross G, Foley P, Baker C. Actinic prurigo. Photodermatol Photoimmunol Photomed. 2008;24(5):272–5.

    Article  PubMed  Google Scholar 

  55. Choi D, Kannan S, Lim HW. Evaluation of patients with photodermatoses. Dermatol Clin. 2014;32(3):267–75 (vii).

    Article  PubMed  CAS  Google Scholar 

  56. Hojyo-Tomoka MT, Vega-Memije ME, Cortes-Franco R, Dominguez-Soto L. Diagnosis and treatment of actinic prurigo. Dermatol Ther. 2003;16(1):40–4.

    Article  PubMed  Google Scholar 

  57. Cuevas-Gonzalez JC, Lievanos-Estrada Z, Vega-Memije ME, Hojyo-Tomoka MT, Dominguez-Soto L. Correlation of serum IgE levels and clinical manifestations in patients with actinic prurigo. An Bras Dermatol. 2016;91(1):23–6.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Crouch R, Foley P, Baker C. Actinic prurigo: a retrospective analysis of 21 cases referred to an Australian photobiology clinic. Australas J Dermatol. 2002;43(2):128–32.

    Article  PubMed  Google Scholar 

  59. Kerr AC, Ferguson J. Actinic prurigo deterioration due to degradation of DermaGard window film. Br J Dermatol. 2007;157(3):619–20.

    Article  PubMed  CAS  Google Scholar 

  60. Lane PR, Moreland AA, Hogan DJ. Treatment of actinic prurigo with intermittent short-course topical 0.05% clobetasol 17-propionate. A preliminary report. Arch Dermatol. 1990;126(9):1211–3.

    Article  PubMed  CAS  Google Scholar 

  61. van de Pas CB, Kelly DA, Seed PT, Young AR, Hawk JL, Walker SL. Ultraviolet-radiation-induced erythema and suppression of contact hypersensitivity responses in patients with polymorphic light eruption. J Investig Dermatol. 2004;122(2):295–9.

    Article  PubMed  Google Scholar 

  62. Food and Drug Administration. Thalomid (thalidomide) NDA # 020785. New Jersey: Celgene Corporation. https://www.accessdata.fda.gov/drugsatfda_docs/nda/98/020785s000_ThalidomideTOC.cfm.

  63. Arrese JE, Dominguez-Soto L, Hojyo-Tomoka MT, Vega-Memije E, Cortes-Franco R, Guevara E, et al. Effectors of inflammation in actinic prurigo. J Am Acad Dermatol. 2001;44(6):957–61.

    Article  PubMed  CAS  Google Scholar 

  64. Torres-Alvarez B, Castanedo-Cazares JP, Moncada B. Pentoxifylline in the treatment of actinic prurigo. A preliminary report of 10 patients. Dermatology. 2004;208(3):198–201.

    Article  PubMed  CAS  Google Scholar 

  65. Lestarini D, Khoo LS, Goh CL. The clinical features and management of actinic prurigo: a retrospective study. Photodermatol Photoimmunol Photomed. 1999;15(5):183–7.

    Article  PubMed  CAS  Google Scholar 

  66. Umana A, Gomez A, Duran MM, Porras L. Lymphocyte subtypes and adhesion molecules in actinic prurigo: observations with cyclosporin A. Int J Dermatol. 2002;41(3):139–45.

    Article  PubMed  CAS  Google Scholar 

  67. Gupta G, Man I, Kemmett D. Hydroa vacciniforme: a clinical and follow-up study of 17 cases. J Am Acad Dermatol. 2000;42(2 Pt 1):208–13.

    Article  PubMed  CAS  Google Scholar 

  68. Nitiyarom R, Wongpraparut C. Hydroa vacciniforme and solar urticaria. Dermatol Clin. 2014;32(3):345–53 (viii).

    Article  PubMed  CAS  Google Scholar 

  69. Chen CC, Chang KC, Medeiros LJ, Lee JY. Hydroa vacciniforme and hydroa vacciniforme-like T-cell lymphoma: an uncommon event for transformation. J Cutan Pathol. 2016;43(12):1102–11.

    Article  PubMed  Google Scholar 

  70. Iwatsuki K, Satoh M, Yamamoto T, Oono T, Morizane S, Ohtsuka M, et al. Pathogenic link between hydroa vacciniforme and Epstein–Barr virus-associated hematologic disorders. Arch Dermatol. 2006;142(5):587–95.

    Article  PubMed  CAS  Google Scholar 

  71. Cohen JI, Kimura H, Nakamura S, Ko YH, Jaffe ES. Epstein–Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8–9 September 2008. Ann Oncol Off J Eur Soc Med Oncol. 2009;20(9):1472–82.

    Article  CAS  Google Scholar 

  72. Cho KH, Lee SH, Kim CW, Jeon YK, Kwon IH, Cho YJ, et al. Epstein-Barr virus-associated lymphoproliferative lesions presenting as a hydroa vacciniforme-like eruption: an analysis of six cases. Br J Dermatol. 2004;151(2):372–80.

    Article  PubMed  Google Scholar 

  73. Lee HY, Baek JO, Lee JR, Park SH, Jeon IS, Roh JY. Atypical hydroa vacciniforme-like Epstein–Barr virus associated T/NK-cell lymphoproliferative disorder. Am J Dermatopathol. 2012;34(8):e119–24.

    Article  PubMed  Google Scholar 

  74. Barrionuevo C, Anderson VM, Zevallos-Giampietri E, Zaharia M, Misad O, Bravo F, et al. Hydroa-like cutaneous T-cell lymphoma: a clinicopathologic and molecular genetic study of 16 pediatric cases from Peru. Appl Immunohistochem Mol Morphol AIMM. 2002;10(1):7–14.

    PubMed  Google Scholar 

  75. Sonnex TS, Hawk JL. Hydroa vacciniforme: a review of ten cases. Br J Dermatol. 1988;118(1):101–8.

    Article  PubMed  CAS  Google Scholar 

  76. Chantorn R, Lim HW, Shwayder TA. Photosensitivity disorders in children: part I. J Am Acad Dermatol. 2012;67(6):1093.e1–18 (quiz 111-2).

    Article  Google Scholar 

  77. Huggins RH, Leithauser LA, Eide MJ, Hexsel CL, Jacobsen G, Lim HW. Quality of life assessment and disease experience of patient members of a web-based hydroa vacciniforme support group. Photodermatol Photoimmunol Photomed. 2009;25(4):209–15.

    Article  PubMed  Google Scholar 

  78. Millard TP, Hawk JL. Photosensitivity disorders: cause, effect and management. Am J Clin Dermatol. 2002;3(4):239–46.

    Article  PubMed  Google Scholar 

  79. Bruderer P, Shahabpour M, Christoffersen S, Andre J, Ledoux M. Hydroa vacciniforme treated by a combination of beta-carotene and canthaxanthin. Dermatology. 1995;190(4):343–5.

    Article  PubMed  CAS  Google Scholar 

  80. Goldgeier MH, Nordlund JJ, Lucky AW, Sibrack LA, McCarthy MJ, McGuire J. Hydroa vacciniforme: diagnosis and therapy. Arch Dermatol. 1982;118(8):588–91.

    Article  PubMed  CAS  Google Scholar 

  81. Blackwell V, McGregor JM, Hawk JL. Hydroa vacciniforme presenting in an adult successfully treated with cyclosporin A. Clin Exp Dermatol. 1998;23(2):73–6.

    Article  PubMed  CAS  Google Scholar 

  82. Modeste AB, Cordel N, Balguerie X, Leroy D, Lauret P, Joly P. Hydroa vacciniforme: dietary fish oil. Ann Dermatol Venereol. 2001;128(3 Pt 1):247–9.

    PubMed  CAS  Google Scholar 

  83. Lysell J, Wiegleb Edstrom D, Linde A, Carlsson G, Malmros-Svennilson J, Westermark A, et al. Antiviral therapy in children with hydroa vacciniforme. Acta Derm Venereol. 2009;89(4):393–7.

    Article  PubMed  CAS  Google Scholar 

  84. Menage H, Ross JS, Norris PG, Hawk JL, White IR. Contact and photocontact sensitization in chronic actinic dermatitis: sesquiterpene lactone mix is an important allergen. Br J Dermatol. 1995;132(4):543–7.

    Article  PubMed  CAS  Google Scholar 

  85. Lim HW, Morison WL, Kamide R, Buchness MR, Harris R, Soter NA. Chronic actinic dermatitis. An analysis of 51 patients evaluated in the United States and Japan. Arch Dermatol. 1994;130(10):1284–9.

    Article  PubMed  CAS  Google Scholar 

  86. Russell SC, Dawe RS, Collins P, Man I, Ferguson J. The photosensitivity dermatitis and actinic reticuloid syndrome (chronic actinic dermatitis) occurring in seven young atopic dermatitis patients. Br J Dermatol. 1998;138(3):496–501.

    Article  PubMed  CAS  Google Scholar 

  87. Ogboli MI, Rhodes LE. Chronic actinic dermatitis in young atopic dermatitis sufferers. Br J Dermatol. 2000;142(4):845.

    Article  PubMed  CAS  Google Scholar 

  88. Que SK, Brauer JA, Soter NA, Cohen DE. Chronic actinic dermatitis: an analysis at a single institution over 25 years. Dermatitis Contact Atopic Occup Drug. 2011;22(3):147–54.

    Google Scholar 

  89. Tan KW, Haylett AK, Ling TC, Rhodes LE. Comparison of demographic and photobiological features of chronic actinic dermatitis in patients with lighter vs darker skin types. JAMA Dermatol. 2017;153(5):427–35.

    Article  PubMed  PubMed Central  Google Scholar 

  90. Lim HW, Cohen D, Soter NA. Chronic actinic dermatitis: results of patch and photopatch tests with Compositae, fragrances, and pesticides. J Am Acad Dermatol. 1998;38(1):108–11.

    Article  PubMed  CAS  Google Scholar 

  91. Hawk J, Lim HW. Chronic actinic dermatitis. In: Lim H, Hönigsmann H, Hawk J, editors. Photodermatology. New York: Informa Healthcare; 2007.

    Google Scholar 

  92. Hawk J. Photodermatology. New York: Oxford University Press; 1999.

    Google Scholar 

  93. Paek SY, Lim HW. Chronic actinic dermatitis. Dermatol Clin. 2014;32(3):355–61.

    Article  PubMed  CAS  Google Scholar 

  94. Frain-Bell W. Photosensitivity and Compositae dermatitis. Clin Dermatol. 1986;4(2):122–6.

    Article  PubMed  CAS  Google Scholar 

  95. Hawk JL, Magnus IA. Chronic actinic dermatitis–an idiopathic photosensitivity syndrome including actinic reticuloid and photosensitive eczema [proceedings]. Br J Dermatol. 1979;101(Suppl 17):24.

    PubMed  Google Scholar 

  96. Agar N, Morris S, Russell-Jones R, Hawk J, Whittaker S. Case report of four patients with erythrodermic cutaneous T-cell lymphoma and severe photosensitivity mimicking chronic actinic dermatitis. Br J Dermatol. 2009;160(3):698–703.

    Article  PubMed  CAS  Google Scholar 

  97. Moseley H, Ferguson J. The risk to normal and photosensitive individuals from exposure to light from compact fluorescent lamps. Photodermatol Photoimmunol Photomed. 2011;27(3):131–7.

    Article  PubMed  Google Scholar 

  98. Bhari N, Gupta S. Tacrolimus 0.1% ointment applied under occlusion using cling film clears chronic actinic dermatitis resistant to systemic treatment. Int J Dermatol. 2017;56(6):e139–41.

    Article  PubMed  Google Scholar 

  99. Norris PG, Camp RD, Hawk JL. Actinic reticuloid: response to cyclosporine. J Am Acad Dermatol. 1989;21(2 Pt 1):307–9.

    Article  PubMed  CAS  Google Scholar 

  100. Gardeazabal J, Arregui MA, Gil N, Landa N, Raton JA, Diaz-Perez JL. Successful treatment of musk ketone-induced chronic actinic dermatitis with cyclosporine and PUVA. J Am Acad Dermatol. 1992;27(5 Pt 2):838–42.

    Article  PubMed  CAS  Google Scholar 

  101. Murphy GM, Maurice PD, Norris PG, Morris RW, Hawk JL. Azathioprine treatment in chronic actinic dermatitis: a double-blind controlled trial with monitoring of exposure to ultraviolet radiation. Br J Dermatol. 1989;121(5):639–46.

    Article  PubMed  CAS  Google Scholar 

  102. Leigh IM, Hawk JL. Treatment of chronic actinic dermatitis with azathioprine. Br J Dermatol. 1984;110(6):691–5.

    Article  PubMed  CAS  Google Scholar 

  103. Thomson MA, Stewart DG, Lewis HM. Chronic actinic dermatitis treated with mycophenolate mofetil. Br J Dermatol. 2005;152(4):784–6.

    Article  PubMed  CAS  Google Scholar 

  104. Vesely MD, Imaeda S, King BA. Tofacitinib citrate for the treatment of refractory, severe chronic actinic dermatitis. JAAD Case Rep. 2017;3(1):4–6.

    Article  PubMed  Google Scholar 

  105. Chee SN, Novakovic L, Fassihi H, Garibaldinos T, Sarkany R. Chronic actinic dermatitis: successful treatment with PUVA photochemotherapy. Br J Dermatol. 2018;178(3):e189–90. https://doi.org/10.1111/bjd.15969.

    Article  PubMed  CAS  Google Scholar 

  106. Dawe RS, Crombie IK, Ferguson J. The natural history of chronic actinic dermatitis. Arch Dermatol. 2000;136(10):1215–20.

    Article  PubMed  CAS  Google Scholar 

  107. Sugita K, Shimauchi T, Tokura Y. Chronic actinic dermatitis associated with adult T-cell leukemia. J Am Acad Dermatol. 2005;52(2 Suppl 1):38–40.

    Article  PubMed  Google Scholar 

  108. Adachi Y, Horio T. Chronic actinic dermatitis in a patient with adult T-cell leukemia. Photodermatol Photoimmunol Photomed. 2008;24(3):147–9.

    Article  PubMed  Google Scholar 

  109. Thomsen K. The development of Hodgkin’s disease in a patient with actinic reticuloid. Clin Exp Dermatol. 1977;2(2):109–13.

    Article  PubMed  CAS  Google Scholar 

  110. De Silva BD, McLaren K, Kavanagh GM. Photosensitive mycosis fungoides or actinic reticuloid? Br J Dermatol. 2000;142(6):1221–7.

    Article  PubMed  Google Scholar 

  111. Bilsland D, Crombie IK, Ferguson J. The photosensitivity dermatitis and actinic reticuloid syndrome: no association with lymphoreticular malignancy. Br J Dermatol. 1994;131(2):209–14.

    Article  PubMed  CAS  Google Scholar 

  112. Norris PG, Newton JA, Camplejohn RS, Hawk JL. A flow cytometric study of actinic reticuloid. Clin Exp Dermatol. 1989;14(2):128–31.

    Article  PubMed  CAS  Google Scholar 

  113. Kerr HA, Lim HW. Photodermatoses in African Americans: a retrospective analysis of 135 patients over a 7-year period. J Am Acad Dermatol. 2007;57(4):638–43.

    Article  PubMed  Google Scholar 

  114. Nakamura M, Henderson M, Jacobsen G, Lim HW. Comparison of photodermatoses in African-Americans and Caucasians: a follow-up study. Photodermatol Photoimmunol Photomed. 2014;30(5):231–6.

    Article  PubMed  Google Scholar 

  115. Beattie P, Dawe RS, Ibbotson SH, Ferguson J. Characteristics and prognosis or idiopathic solar urticaria: a cohort of 87 cases. Arch Dermatol. 2003;139:1149–54.

    Article  PubMed  Google Scholar 

  116. Tuchinda C, Leenutaphong V, Sudtim S, Lim HW. Fixed solar urticaria induced by UVA and visible light: a report of a case. Photodermatol Photoimmunol Photomed. 2005;21:97–9.

    Article  PubMed  CAS  Google Scholar 

  117. Wessendorf U, Hanneken S, Haust M, Neumann NJ. Fixed solar urticaria with delayed onset. J Am Acad Dermatol. 2009;60(4):695–7.

    Article  PubMed  Google Scholar 

  118. Kaidbey KH, Kligman AM. Clinical and histological study of coal tar phototoxicity in humans. Arch Dermatol. 1977;113(5):592–5.

    Article  PubMed  CAS  Google Scholar 

  119. Kurumaji Y, Shono M. Drug-induced solar urticaria due to repirinast. Dermatology. 1994;188(2):117–21.

    Article  PubMed  CAS  Google Scholar 

  120. Tajima S, Fukunaga A, Nishigori C. A case of atorvastatin-induced solar urticaria. Photodermatol Photoimmunol Photomed. 2016;32(5–6):317–9.

    Article  PubMed  Google Scholar 

  121. Kuo S, Sivamani RK. UVB-sensitive solar urticaria possibly associated with terbinafine. Dermatol Online J. 2014;20(3).

  122. Yap LM, Foley PA, Crouch RB, Baker CS. Drug-induced solar urticaria due to tetracycline. Australas J Dermatol. 2000;41(3):181–4.

    Article  PubMed  CAS  Google Scholar 

  123. Morison WL. Solar urticaria due to progesterone compounds in oral contraceptives. Photodermatol Photoimmunol Photomed. 2003;19(3):155–6.

    Article  PubMed  Google Scholar 

  124. Hay RA, Pan JY. Persistent photosensitivity and solar urticaria following SJS/TEN. J Eur Acad Dermatol Venereol. 2015;29(1):190–1.

    Article  PubMed  CAS  Google Scholar 

  125. Kullavanijaya P, Lim HW. Photoprotection. J Am Acad Dermatol. 2005;52(6):937–58 (quiz 59–62).

    Article  PubMed  Google Scholar 

  126. Botto NC, Warshaw EM. Solar urticaria. J Am Acad Dermatol. 2008;59(6):909–20 (quiz 21–22).

    Article  PubMed  Google Scholar 

  127. Tokura Y, Takigawa M, Yamauchi T, Yamada M. Solar urticaria: a case with good therapeutic response to cimetidine. Dermatologica. 1986;173(5):224–8.

    Article  PubMed  CAS  Google Scholar 

  128. Neittaanmaki H, Jaaskelainen T, Harvima RJ, Fraki JE. Solar urticaria: demonstration of histamine release and effective treatment with doxepin. Photodermatology. 1989;6(1):52–5.

    PubMed  CAS  Google Scholar 

  129. Grundmann SA, Stander S, Luger TA, Beissert S. Antihistamine combination treatment for solar urticaria. Br J Dermatol. 2008;158(6):1384–6.

    Article  PubMed  CAS  Google Scholar 

  130. Levi A, Enk CD. Treatment of solar urticaria using antihistamine and leukotriene receptor antagonist combinations tailored to disease severity. Photodermatol Photoimmunol Photomed. 2015;31(6):302–6.

    Article  PubMed  CAS  Google Scholar 

  131. Beissert S, Stander H, Schwarz T. UVA rush hardening for the treatment of solar urticaria. J Am Acad Dermatol. 2000;42(6):1030–2.

    Article  PubMed  CAS  Google Scholar 

  132. Dawe RS, Ferguson J. Prolonged benefit following ultraviolet A phototherapy for solar urticaria. Br J Dermatol. 1997;137(1):144–8.

    Article  PubMed  CAS  Google Scholar 

  133. Calzavara-Pinton P, Zane C, Rossi M, Sala R, Venturini M. Narrowband ultraviolet B phototherapy is a suitable treatment option for solar urticaria. J Am Acad Dermatol. 2012;67(1):e5–9.

    Article  PubMed  Google Scholar 

  134. Duschet P, Leyen P, Schwarz T, Hocker P, Greiter J, Gschnait F. Solar urticaria—effective treatment by plasmapheresis. Clin Exp Dermatol. 1987;12(3):185–8.

    Article  PubMed  CAS  Google Scholar 

  135. Maurer M, Metz M, Brehler R, Hillen U, Jakob T, Mahler V, et al. Omalizumab treatment in patients with chronic inducible urticaria: a systematic review of published evidence. J Allergy Clin Immunol. 2018;141(2):638–49. https://doi.org/10.1016/j.jaci.2017.06.032.

    Article  PubMed  CAS  Google Scholar 

  136. Aubin F, Avenel-Audran M, Jeanmougin M, Adamski H, Peyron JL, Marguery MC, et al. Omalizumab in patients with severe and refractory solar urticaria: a phase II multicentric study. J Am Acad Dermatol. 2016;74(3):574–5.

    Article  PubMed  CAS  Google Scholar 

  137. Baliu-Pique C, Aguilera Peiro P. Three cases of solar urticaria successfully treated with omalizumab. J Eur Acad Dermatol Venereol. 2016;30(4):704–6.

    Article  PubMed  CAS  Google Scholar 

  138. Maksimovic L, Fremont G, Jeanmougin M, Dubertret L, Viguier M. Solar urticaria successfully treated with intravenous immunoglobulins. Dermatology. 2009;218(3):252–4.

    Article  PubMed  Google Scholar 

  139. Frank J, Poblete-Butierrez PA, Lang E. Porphyria. In: Bolognia J, Jorizo JL, Schaffer JV, editors. Dermatology. 4th ed. London: Elsevier; 2018. p. 773–83.

    Google Scholar 

  140. Balwani M, Naik H, Anderson KE, Bissell DM, Bloomer J, Bonkovsky HL, et al. Clinical, biochemical, and genetic characterization of North American patients with erythropoietic protoporphyria and X-linked protoporphyria. JAMA Dermatol. 2017;153(8):789–96.

    Article  PubMed  PubMed Central  Google Scholar 

  141. Horner ME, Alikhan A, Tintle S, Tortorelli S, Davis DM, Hand JL. Cutaneous porphyrias part I: epidemiology, pathogenesis, presentation, diagnosis, and histopathology. Int J Dermatol. 2013;52(12):1464–80.

    Article  PubMed  Google Scholar 

  142. Parker M, Corrigall AV, Hift RJ, Meissner PN. Molecular characterization of erythropoietic protoporphyria in South Africa. Br J Dermatol. 2008;159(1):182–91.

    Article  PubMed  CAS  Google Scholar 

  143. Marko PB, Miljkovic J, Gorenjak M, Povalej P, Kansky A. Erythropoietic protoporphyria patients in Slovenia. Acta dermatovenerologica Alpina, Pannonica, et Adriatica. 2007;16(3):99–102.

    PubMed  CAS  Google Scholar 

  144. Poh-Fitzpatrick MB. The “priming phenomenon” in the acute phototoxicity of erythropoietic protoporphyria. J Am Acad Dermatol. 1989;21(2 Pt 1):311.

    Article  PubMed  CAS  Google Scholar 

  145. Bissell DM, Anderson KE, Bonkovsky HL. Porphyria. N Engl J Med. 2017;377(9):862–72.

    Article  PubMed  CAS  Google Scholar 

  146. Holme SA, Whatley SD, Roberts AG, Anstey AV, Elder GH, Ead RD, et al. Seasonal palmar keratoderma in erythropoietic protoporphyria indicates autosomal recessive inheritance. J Investig Dermatol. 2009;129(3):599–605.

    Article  PubMed  CAS  Google Scholar 

  147. Frank M, Doss MO. Severe liver disease in protoporphyria. Curr Probl Dermatol. 1991;20:160–7.

    Article  PubMed  CAS  Google Scholar 

  148. Balwani M, Bloomer J, Desnick R, Porphyrias Consortium of the NIH-Sponsored Rare Diseases Clinical Research Network. Erythropoietic protoporphyria, autosomal recessive. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington; 1993–2018.

  149. Whatley SD, Badminton MN. Role of genetic testing in the management of patients with inherited porphyria and their families. Ann Clin Biochem. 2013;50(Pt 3):204–16.

    Article  PubMed  CAS  Google Scholar 

  150. Wahlin S, Srikanthan N, Hamre B, Harper P, Brun A. Protection from phototoxic injury during surgery and endoscopy in erythropoietic protoporphyria. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc. 2008;14(9):1340–6.

    Google Scholar 

  151. Spelt JM, de Rooij FW, Wilson JH, Zandbergen AA. Vitamin D deficiency in patients with erythropoietic protoporphyria. J Inherit Metab Dis. 2010;33(Suppl 3):S1–4.

    Article  PubMed  Google Scholar 

  152. McCullough AJ, Barron D, Mullen KD, Petrelli M, Park MC, Mukhtar H, et al. Fecal protoporphyrin excretion in erythropoietic protoporphyria: effect of cholestyramine and bile acid feeding. Gastroenterology. 1988;94(1):177–81.

    Article  PubMed  CAS  Google Scholar 

  153. Bosio GN, Breitenbach T, Parisi J, Reigosa M, Blaikie FH, Pedersen BW, et al. Antioxidant beta-carotene does not quench singlet oxygen in mammalian cells. J Am Chem Soc. 2013;135(1):272–9.

    Article  PubMed  CAS  Google Scholar 

  154. Tu JH, Sheu SL, Teng JM. Novel treatment using cimetidine for erythropoietic protoporphyria in children. JAMA Dermatol. 2016;152(11):1258–61.

    Article  PubMed  Google Scholar 

  155. Yamamoto S, Hirano Y, Horie Y. Cimetidine reduces erythrocyte protoporphyrin in erythropoietic protoporphyria. Am J Gastroenterol. 1993;88(9):1465–6.

    PubMed  CAS  Google Scholar 

  156. Eefsen M, Rasmussen A, Wulf HC, Brock A, Hansen BA. Erythropoietic protoporphyria and pretransplantation treatment with nonbiological liver assist devices. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc. 2007;13(5):655–7.

    Google Scholar 

  157. Garcia-Martin P, De Argila D, To-Figueras J, Llamas-Velasco M, Fraga J, Garcia-Diez A. Phototolerance induced by narrow-band UVB phototherapy in severe erythropoietic protoporphyria. Photodermatol Photoimmunol Photomed. 2012;28(5):261–3.

    Article  PubMed  Google Scholar 

  158. Jansen R, Wang SQ, Burnett M, Osterwalder U, Lim HW. Photoprotection: part I. Photoprotection by naturally occurring, physical, and systemic agents. J Am Acad Dermatol. 2013;69(6):853.e1–12 (quiz 65–66).

    Article  CAS  Google Scholar 

  159. Langendonk JG, Balwani M, Anderson KE, Bonkovsky HL, Anstey AV, Bissell DM, et al. Afamelanotide for erythropoietic protoporphyria. N Engl J Med. 2015;373(1):48–59.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  160. Bustamante J, Bredeston L, Malanga G, Mordoh J. Role of melanin as a scavenger of active oxygen species. Pigment Cell Res. 1993;6(5):348–53.

    Article  PubMed  CAS  Google Scholar 

  161. Kollias N, Sayre RM, Zeise L, Chedekel MR. Photoprotection by melanin. J Photochem Photobiol B. 1991;9(2):135–60.

    Article  PubMed  CAS  Google Scholar 

  162. Minder EI, Barman-Aksoezen J, Schneider-Yin X. Pharmacokinetics and pharmacodynamics of afamelanotide and its clinical use in treating dermatologic disorders. Clin Pharmacokinet. 2017;56(8):815–23.

    Article  PubMed  CAS  Google Scholar 

  163. Anstey AV, Hift RJ. Liver disease in erythropoietic protoporphyria: insights and implications for management. Gut. 2007;56(7):1009–18.

    PubMed  PubMed Central  CAS  Google Scholar 

  164. Singal AK, Parker C, Bowden C, Thapar M, Liu L, McGuire BM. Liver transplantation in the management of porphyria. Hepatology (Baltimore, Md). 2014;60(3):1082–9.

    Article  PubMed Central  Google Scholar 

  165. Nowaczyk MJM. Smith–Lemli–Opitz syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington; 1993–2018.

  166. Nowaczyk MJ, Tan M, Hamid JS, Allanson JE. Smith–Lemli–Opitz syndrome: objective assessment of facial phenotype. Am J Med Genet Part A. 2012;158a(5):1020–8.

    Article  PubMed  Google Scholar 

  167. Tint GS, Irons M, Elias ER, Batta AK, Frieden R, Chen TS, et al. Defective cholesterol biosynthesis associated with the Smith–Lemli–Opitz syndrome. N Engl J Med. 1994;330(2):107–13.

    Article  PubMed  CAS  Google Scholar 

  168. Cunniff C, Kratz LE, Moser A, Natowicz MR, Kelley RI. Clinical and biochemical spectrum of patients with RSH/Smith–Lemli–Opitz syndrome and abnormal cholesterol metabolism. Am J Med Genet. 1997;68(3):263–9.

    Article  PubMed  CAS  Google Scholar 

  169. Johnson VP. Smith–Lemli–Opitz syndrome: review and report of two affected siblings. Zeitschrift fur Kinderheilkunde. 1975;119(4):221–34.

    Article  PubMed  CAS  Google Scholar 

  170. Kelley RI, Hennekam RC. The Smith–Lemli–Opitz syndrome. J Med Genet. 2000;37(5):321–35.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  171. Chasalow FI, Blethen SL, Taysi K. Possible abnormalities of steroid secretion in children with Smith–Lemli–Opitz syndrome and their parents. Steroids. 1985;46(4–5):827–43.

    Article  PubMed  CAS  Google Scholar 

  172. Pinsky L, Digeorge AM. A familial syndrome of facial and skeletal anomalies associated with genital abnormality in the male and noraml genitals in the female: another cause of male pseudohermaphroditism. J Pediatr. 1965;66:1049–54.

    Article  PubMed  CAS  Google Scholar 

  173. Chemaitilly W, Goldenberg A, Baujat G, Thibaud E, Cormier-Daire V, Abadie V. Adrenal insufficiency and abnormal genitalia in a 46XX female with Smith–Lemli–Opitz syndrome. Horm Res. 2003;59(5):254–6.

    PubMed  CAS  Google Scholar 

  174. Lee RW, Conley SK, Gropman A, Porter FD, Baker EH. Brain magnetic resonance imaging findings in Smith–Lemli–Opitz syndrome. Am J Med Genet Part A. 2013;161a(10):2407–19.

    PubMed  Google Scholar 

  175. Lin AE, Ardinger HH, Ardinger RH Jr, Cunniff C, Kelley RI. Cardiovascular malformations in Smith–Lemli–Opitz syndrome. Am J Med Genet. 1997;68(3):270–8.

    Article  PubMed  CAS  Google Scholar 

  176. Finley SC, Finley WH, Monsky DB. Cataracts in a girl with features of the Smith–Lemli–Opitz syndrome. J Pediatr. 1969;75(4):706–7.

    Article  PubMed  CAS  Google Scholar 

  177. Atchaneeyasakul LO, Linck LM, Connor WE, Weleber RG, Steiner RD. Eye findings in 8 children and a spontaneously aborted fetus with RSH/Smith–Lemli–Opitz syndrome. Am J Med Genet. 1998;80(5):501–5.

    Article  PubMed  CAS  Google Scholar 

  178. Ryan AK, Bartlett K, Clayton P, Eaton S, Mills L, Donnai D, et al. Smith–Lemli–Opitz syndrome: a variable clinical and biochemical phenotype. J Med Genet. 1998;35(7):558–65.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  179. Krajewska-Walasek M, Gradowska W, Ryzko J, Socha P, Chmielik J, Szaplyko W, et al. Further delineation of the classical Smith–Lemli–Opitz syndrome phenotype at different patient ages: clinical and biochemical studies. Clin Dysmorphol. 1999;8(1):29–40.

    Article  PubMed  CAS  Google Scholar 

  180. Anstey AV, Taylor CR. Photosensitivity in the Smith–Lemli–Opitz syndrome: the US experience of a new congenital photosensitivity syndrome. J Am Acad Dermatol. 1999;41(1):121–3.

    Article  PubMed  CAS  Google Scholar 

  181. Starck L, Lovgren-Sandblom A, Bjorkhem I. Cholesterol treatment forever? The first Scandinavian trial of cholesterol supplementation in the cholesterol-synthesis defect Smith–Lemli–Opitz syndrome. J Intern Med. 2002;252(4):314–21.

    Article  PubMed  CAS  Google Scholar 

  182. Azurdia RM, Anstey AV, Rhodes LE. Cholesterol supplementation objectively reduces photosensitivity in the Smith–Lemli–Opitz syndrome. Br J Dermatol. 2001;144(1):143–5.

    Article  PubMed  CAS  Google Scholar 

  183. Calmels N, Greff G, Obringer C, Kempf N, Gasnier C, Tarabeux J, et al. Uncommon nucleotide excision repair phenotypes revealed by targeted high-throughput sequencing. Orphanet J Rare Dis. 2016;22(11):26.

    Article  Google Scholar 

  184. Cleaver JE, Lam ET, Revet I. Disorders of nucleotide excision repair: the genetic and molecular basis of heterogeneity. Nat Rev Genet. 2009;10(11):756–68.

    Article  PubMed  CAS  Google Scholar 

  185. Kleijer WJ, Laugel V, Berneburg M, Nardo T, Fawcett H, Gratchev A, et al. Incidence of DNA repair deficiency disorders in western Europe: Xeroderma pigmentosum. Cockayne syndrome and trichothiodystrophy. DNA Repair. 2008;7(5):744–50.

    Article  PubMed  CAS  Google Scholar 

  186. Kraemer KH, Lee MM, Andrews AD, Lambert WC. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch Dermatol. 1994;130(8):1018–21.

    Article  PubMed  CAS  Google Scholar 

  187. Bradford PT, Goldstein AM, Tamura D, Khan SG, Ueda T, Boyle J, et al. Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair. J Med Genet. 2011;48(3):168–76.

    Article  PubMed  Google Scholar 

  188. Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol. 1987;123(2):241–50.

    Article  PubMed  CAS  Google Scholar 

  189. Moriwaki S, Kanda F, Hayashi M, Yamashita D, Sakai Y, Nishigori C. Xeroderma pigmentosum clinical practice guidelines. J Dermatol. 2017;44(10):1087–96. https://doi.org/10.1111/1346-8138.13907.

    Article  PubMed  Google Scholar 

  190. DiGiovanna JJ, Kraemer KH. Shining a light on xeroderma pigmentosum. J Investig Dermatol. 2012;132(3 Pt 2):785–96.

    Article  PubMed  CAS  Google Scholar 

  191. Brooks PJ. The case for 8,5′-cyclopurine-2′-deoxynucleosides as endogenous DNA lesions that cause neurodegeneration in xeroderma pigmentosum. Neuroscience. 2007;145(4):1407–17.

    Article  PubMed  CAS  Google Scholar 

  192. Sethi M, Lehmann AR, Fawcett H, Stefanini M, Jaspers N, Mullard K, et al. Patients with xeroderma pigmentosum complementation groups C, E and V do not have abnormal sunburn reactions. Br J Dermatol. 2013;169(6):1279–87.

    Article  PubMed  CAS  Google Scholar 

  193. Kraemer KH, DiGiovanna JJ. Xeroderma pigmentosum. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews®. Seattle (WA): University of Washington; 1993–2018.

  194. Lai JP, Liu YC, Alimchandani M, Liu Q, Aung PP, Matsuda K, et al. The influence of DNA repair on neurological degeneration, cachexia, skin cancer and internal neoplasms: autopsy report of four xeroderma pigmentosum patients (XP-A, XP-C and XP-D). Acta Neuropathol Commun. 2013;8(1):4.

    Article  Google Scholar 

  195. Tanioka M, Masaki T, Ono R, Nagano T, Otoshi-Honda E, Matsumura Y, et al. Molecular analysis of DNA polymerase eta gene in Japanese patients diagnosed as xeroderma pigmentosum variant type. J Investig Dermatol. 2007;127(7):1745–51.

    Article  PubMed  CAS  Google Scholar 

  196. Yang JQ, Chen XY, Engle MY, Wang JY. Multiple facial basal cell carcinomas in xeroderma pigmentosum treated with topical imiquimod 5% cream. Dermatol Ther. 2015;28(4):243–7.

    Article  PubMed  Google Scholar 

  197. Yarosh D, Klein J, O’Connor A, Hawk J, Rafal E, Wolf P. Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Xeroderma Pigmentosum Study Group. Lancet (London, England). 2001;357(9260):926–9.

    Article  CAS  Google Scholar 

  198. Giustini S, Miraglia E, Berardesca E, Milani M, Calvieri S. Preventive long-term effects of a topical film-forming medical device with ultra-high UV protection filters and DNA repair enzyme in xeroderma pigmentosum: a retrospective study of eight cases. Case Rep Dermatol. 2014;6(3):222–6.

    Article  PubMed  PubMed Central  Google Scholar 

  199. Fassihi H, Sethi M, Fawcett H, Wing J, Chandler N, Mohammed S, et al. Deep phenotyping of 89 xeroderma pigmentosum patients reveals unexpected heterogeneity dependent on the precise molecular defect. Proc Natl Acad Sci USA. 2016;113(9):E1236–45.

    Article  PubMed  CAS  Google Scholar 

  200. Pena SD, Evans J, Hunter AG. COFS syndrome revisited. Birth Defects Orig Artic Ser. 1978;14(6b):205–13.

    PubMed  CAS  Google Scholar 

  201. Capell BC, Tlougan BE, Orlow SJ. From the rarest to the most common: insights from progeroid syndromes into skin cancer and aging. J Investig Dermatol. 2009;129(10):2340–50.

    Article  PubMed  CAS  Google Scholar 

  202. Yew YW, Giordano CN, Spivak G, Lim HW. Understanding photodermatoses associated with defective DNA repair: photosensitive syndromes without associated cancer predisposition. J Am Acad Dermatol. 2016;75(5):873–82.

    Article  PubMed  Google Scholar 

  203. Wilson BT, Stark Z, Sutton RE, Danda S, Ekbote AV, Elsayed SM, et al. The Cockayne Syndrome Natural History (CoSyNH) study: clinical findings in 102 individuals and recommendations for care. Genet Med Off J Am Coll Med Genet. 2016;18(5):483–93.

    Google Scholar 

  204. Nance MA, Berry SA. Cockayne syndrome: review of 140 cases. Am J Med Genet. 1992;42(1):68–84.

    Article  PubMed  CAS  Google Scholar 

  205. Spivak G. The many faces of Cockayne syndrome. Proc Natl Acad Sci USA. 2004;101(43):15273–4.

    Article  PubMed  CAS  Google Scholar 

  206. Natale V, Raquer H. Xeroderma pigmentosum-Cockayne syndrome complex. Orphanet J Rare Dis. 2017;12(1):65.

    Article  PubMed  PubMed Central  Google Scholar 

  207. Kraemer KH, Patronas NJ, Schiffmann R, Brooks BP, Tamura D, DiGiovanna JJ. Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype–phenotype relationship. Neuroscience. 2007;145(4):1388–96.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  208. Hosseini M, Ezzedine K, Taieb A, Rezvani HR. Oxidative and energy metabolism as potential clues for clinical heterogeneity in nucleotide excision repair disorders. J Investig Dermatol. 2015;135(2):341–51.

    Article  PubMed  CAS  Google Scholar 

  209. Moriwaki S. Hereditary disorders with defective repair of UV-induced DNA damage. Jpn Clin Med. 2013;4:29–35.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  210. Spivak G. UV-sensitive syndrome. Mutat Res. 2005;577(1–2):162–9.

    Article  PubMed  CAS  Google Scholar 

  211. Itoh T, Ono T, Yamaizumi M. A new UV-sensitive syndrome not belonging to any complementation groups of xeroderma pigmentosum or Cockayne syndrome: siblings showing biochemical characteristics of Cockayne syndrome without typical clinical manifestations. Mutat Res. 1994;314(3):233–48.

    Article  PubMed  CAS  Google Scholar 

  212. Horibata K, Iwamoto Y, Kuraoka I, Jaspers NG, Kurimasa A, Oshimura M, et al. Complete absence of Cockayne syndrome group B gene product gives rise to UV-sensitive syndrome but not Cockayne syndrome. Proc Natl Acad Sci USA. 2004;101(43):15410–5.

    Article  PubMed  CAS  Google Scholar 

  213. Nardo T, Oneda R, Spivak G, Vaz B, Mortier L, Thomas P, et al. A UV-sensitive syndrome patient with a specific CSA mutation reveals separable roles for CSA in response to UV and oxidative DNA damage. Proc Natl Acad Sci USA. 2009;106(15):6209–14.

    Article  PubMed  Google Scholar 

  214. Fujiwara Y, Ichihashi M, Kano Y, Goto K, Shimizu K. A new human photosensitive subject with a defect in the recovery of DNA synthesis after ultraviolet-light irradiation. J Investig Dermatol. 1981;77(3):256–63.

    Article  PubMed  CAS  Google Scholar 

  215. Guo J, Hanawalt PC, Spivak G. Comet-FISH with strand-specific probes reveals transcription-coupled repair of 8-oxoGuanine in human cells. Nucleic Acids Res. 2013;41(16):7700–12.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  216. Cleaver JE. Photosensitivity syndrome brings to light a new transcription-coupled DNA repair cofactor. Nat Genet. 2012;44(5):477–8.

    Article  PubMed  CAS  Google Scholar 

  217. Cleaver JE, Brennan-Minnella AM, Swanson RA, Fong KW, Chen J, Chou KM, et al. Mitochondrial reactive oxygen species are scavenged by Cockayne syndrome B protein in human fibroblasts without nuclear DNA damage. Proc Natl Acad Sci USA. 2014;111(37):13487–92.

    Article  PubMed  CAS  Google Scholar 

  218. Chatre L, Biard DS, Sarasin A, Ricchetti M. Reversal of mitochondrial defects with CSB-dependent serine protease inhibitors in patient cells of the progeroid Cockayne syndrome. Proc Natl Acad Sci USA. 2015;112(22):E2910–9.

    Article  PubMed  CAS  Google Scholar 

  219. Spivak G, Itoh T, Matsunaga T, Nikaido O, Hanawalt P, Yamaizumi M. Ultraviolet-sensitive syndrome cells are defective in transcription-coupled repair of cyclobutane pyrimidine dimers. DNA Repair. 2002;1(8):629–43.

    Article  PubMed  CAS  Google Scholar 

  220. Hoeijmakers JH. DNA damage, aging, and cancer. N Engl J Med. 2009;361(15):1475–85.

    Article  PubMed  CAS  Google Scholar 

  221. Gaillard H, Aguilera A. Transcription coupled repair at the interface between transcription elongation and mRNP biogenesis. Biochem Biophys Acta. 2013;1829(1):141–50.

    PubMed  CAS  Google Scholar 

  222. Brown AC, Belser RB, Crounse RG, Wehr RF. A congenital hair defect: trichoschisis with alternating birefringence and low sulfur content. J Investig Dermatol. 1970;54(6):496–509.

    Article  PubMed  CAS  Google Scholar 

  223. Faghri S, Tamura D, Kraemer KH, Digiovanna JJ. Trichothiodystrophy: a systematic review of 112 published cases characterises a wide spectrum of clinical manifestations. J Med Genet. 2008;45(10):609–21.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  224. Brooks BP, Thompson AH, Clayton JA, Chan CC, Tamura D, Zein WM, et al. Ocular manifestations of trichothiodystrophy. Ophthalmology. 2011;118(12):2335–42.

    Article  PubMed  PubMed Central  Google Scholar 

  225. Petrin JH, Meckler KA, Sybert VP. A new variant of trichothiodystrophy with recurrent infections, failure to thrive, and death. Pediatr Dermatol. 1998;15(1):31–4.

    Article  PubMed  CAS  Google Scholar 

  226. Shahrabani-Gargir L, Shomrat R, Yaron Y, Orr-Urtreger A, Groden J, Legum C. High frequency of a common Bloom syndrome Ashkenazi mutation among Jews of Polish origin. Genet Test. 1998;2(4):293–6.

    Article  PubMed  CAS  Google Scholar 

  227. German J, Takebe H. Bloom’s syndrome. XIV. The disorder in Japan. Clin Genet. 1989;35(2):93–110.

    Article  PubMed  CAS  Google Scholar 

  228. Inamadar AC, Palit A. Bloom syndrome in an Indian child. Pediatr Dermatol. 2005;22(2):147–50.

    Article  PubMed  Google Scholar 

  229. Killen MW, Stults DM, Adachi N, Hanakahi L, Pierce AJ. Loss of Bloom syndrome protein destabilizes human gene cluster architecture. Hum Mol Genet. 2009;18(18):3417–28.

    Article  PubMed  CAS  Google Scholar 

  230. Nicotera TM, Notaro J, Notaro S, Schumer J, Sandberg AA. Elevated superoxide dismutase in Bloom’s syndrome: a genetic condition of oxidative stress. Can Res. 1989;49(19):5239–43.

    CAS  Google Scholar 

  231. Lindor NM, Furuichi Y, Kitao S, Shimamoto A, Arndt C, Jalal S. Rothmund-Thomson syndrome due to RECQ4 helicase mutations: report and clinical and molecular comparisons with Bloom syndrome and Werner syndrome. Am J Med Genet. 2000;90(3):223–8.

    Article  PubMed  CAS  Google Scholar 

  232. Guerrero-Gonzalez GA, Martinez-Cabriales SA, Hernandez-Juarez AA, de Jesus Lugo-Trampe J, Espinoza-Gonzalez NA, Gomez-Flores M, et al. Rothmund–Thomson syndrome: a 13-year follow-up. Case Rep Dermatol. 2014;6(2):176–9.

    Article  PubMed  PubMed Central  Google Scholar 

  233. Wang LL, Levy ML, Lewis RA, Chintagumpala MM, Lev D, Rogers M, et al. Clinical manifestations in a cohort of 41 Rothmund–Thomson syndrome patients. Am J Med Genet. 2001;102(1):11–7.

    Article  PubMed  CAS  Google Scholar 

  234. Piquero-Casals J, Okubo AY, Nico MM. Rothmund–Thomson syndrome in three siblings and development of cutaneous squamous cell carcinoma. Pediatr Dermatol. 2002;19(4):312–6.

    Article  PubMed  Google Scholar 

  235. Stinco G, Governatori G, Mattighello P, Patrone P. Multiple cutaneous neoplasms in a patient with Rothmund–Thomson syndrome: case report and published work review. J Dermatol. 2008;35(3):154–61.

    Article  PubMed  Google Scholar 

  236. Wang LL, Plon SE. Rothmund–Thomson syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington; 1993–2018.

  237. Lai-Cheong JE, Parsons M, McGrath JA. The role of kindlins in cell biology and relevance to human disease. Int J Biochem Cell Biol. 2010;42(5):595–603.

    Article  PubMed  CAS  Google Scholar 

  238. Emmert H, Patel H, Brunton VG. Kindlin-1 protects cells from oxidative damage through activation of ERK signalling. Free Radical Biol Med. 2017;108:896–903.

    Article  CAS  Google Scholar 

  239. Lai-Cheong JE, Liu L, Sethuraman G, Kumar R, Sharma VK, Reddy SR, et al. Five new homozygous mutations in the KIND1 gene in Kindler syndrome. J Investig Dermatol. 2007;127(9):2268–70.

    Article  PubMed  CAS  Google Scholar 

  240. Fine J, Mellerio JE. Kindler syndrome. In: Bolognia JLSJ, Cerroni L, Callen JP, Hruza GJ, Jorizzo JL, Lui H, Requena L, Schwarz T, Torrelo A, editors. Dermatology. 4th ed. New York: Elsevier Limited; 2018. p. 549.

    Google Scholar 

  241. Lai-Cheong JE, McGrath JA. Kindler syndrome. Dermatol Clin. 2010;28(1):119–24.

    Article  PubMed  CAS  Google Scholar 

  242. Ashton GH. Kindler syndrome. Clin Exp Dermatol. 2004;29(2):116–21.

    Article  PubMed  CAS  Google Scholar 

  243. El Hachem M, Diociaiuti A, Proto V, Fortugno P, Zambruno G, Castiglia D, et al. Kindler syndrome with severe mucosal involvement in a large Palestinian pedigree. Eur J Dermatol. 2015;25(1):14–9.

    PubMed  Google Scholar 

  244. Lai-Cheong JE, Tanaka A, Hawche G, Emanuel P, Maari C, Taskesen M, et al. Kindler syndrome: a focal adhesion genodermatosis. Br J Dermatol. 2009;160(2):233–42.

    Article  PubMed  CAS  Google Scholar 

  245. Kern JS, Herz C, Haan E, Moore D, Nottelmann S, von Lilien T, et al. Chronic colitis due to an epithelial barrier defect: the role of kindlin-1 isoforms. J Pathol. 2007;213(4):462–70.

    Article  PubMed  CAS  Google Scholar 

  246. Almeida HL Jr, Heckler GT, Fong K, Lai-Cheong J, McGrath J. Sporadic Kindler syndrome with a novel mutation. An Bras Dermatol. 2013;88(6 Suppl 1):212–5.

    Article  PubMed  Google Scholar 

  247. Arita K, Wessagowit V, Inamadar AC, Palit A, Fassihi H, Lai-Cheong JE, et al. Unusual molecular findings in Kindler syndrome. Br J Dermatol. 2007;157(6):1252–6.

    Article  PubMed  CAS  Google Scholar 

  248. Ashton GH, McLean WH, South AP, Oyama N, Smith FJ, Al-Suwaid R, et al. Recurrent mutations in kindlin-1, a novel keratinocyte focal contact protein, in the autosomal recessive skin fragility and photosensitivity disorder, Kindler syndrome. J Investig Dermatol. 2004;122(1):78–83.

    Article  PubMed  CAS  Google Scholar 

  249. Emanuel PO, Rudikoff D, Phelps RG. Aggressive squamous cell carcinoma in Kindler syndrome. Skinmed. 2006;5(6):305–7.

    Article  PubMed  Google Scholar 

  250. Has C, Wessagowit V, Pascucci M, Baer C, Didona B, Wilhelm C, et al. Molecular basis of Kindler syndrome in Italy: novel and recurrent Alu/Alu recombination, splice site, nonsense, and frameshift mutations in the KIND1 gene. J Investig Dermatol. 2006;126(8):1776–83.

    Article  PubMed  CAS  Google Scholar 

  251. Lotem M, Raben M, Zeltser R, Landau M, Sela M, Wygoda M, et al. Kindler syndrome complicated by squamous cell carcinoma of the hard palate: successful treatment with high-dose radiation therapy and granulocyte-macrophage colony-stimulating factor. Br J Dermatol. 2001;144(6):1284–6.

    Article  PubMed  CAS  Google Scholar 

  252. Has C, Burger B, Volz A, Kohlhase J, Bruckner-Tuderman L, Itin P. Mild clinical phenotype of Kindler syndrome associated with late diagnosis and skin cancer. Dermatology. 2010;221(4):309–12.

    Article  PubMed  CAS  Google Scholar 

  253. Yazdanfar A, Hashemi B. Kindler syndrome: report of three cases in a family and a brief review. Int J Dermatol. 2009;48(2):145–9.

    Article  PubMed  Google Scholar 

  254. Lai-Cheong JE, Ussar S, Arita K, Hart IR, McGrath JA. Colocalization of kindlin-1, kindlin-2, and migfilin at keratinocyte focal adhesion and relevance to the pathophysiology of Kindler syndrome. J Investig Dermatol. 2008;128(9):2156–65.

    Article  PubMed  CAS  Google Scholar 

  255. Lai-Cheong JE, Moss C, Parsons M, Almaani N, McGrath JA. Revertant mosaicism in Kindler syndrome. J Investig Dermatol. 2012;132(3 Pt 1):730–2.

    Article  PubMed  CAS  Google Scholar 

  256. Maier K, He Y, Wolfle U, Esser PR, Brummer T, Schempp C, et al. UV-B-induced cutaneous inflammation and prospects for antioxidant treatment in Kindler syndrome. Hum Mol Genet. 2016;25(24):5339–52.

    PubMed  CAS  Google Scholar 

  257. Zapatero-Solana E, Garcia-Gimenez JL, Guerrero-Aspizua S, Garcia M, Toll A, Baselga E, et al. Oxidative stress and mitochondrial dysfunction in Kindler syndrome. Orphanet J Rare Dis. 2014;21(9):211.

    Article  Google Scholar 

  258. Fazel N, Lim HW. Evaluation and management of the patient with photosensitivity. Dermatol Nurs. 2002;14(1):23–4 (7–30).

    PubMed  Google Scholar 

  259. Lim H, Hawk JLM. Evaluation of the photosensitive patients. In: Lim H, Hoenigsmann H, Hawk JLM, editors. Photodermatology. New York: Informa Healthcare; 2007. p. 139–67.

    Google Scholar 

  260. Prevent skin cancer. 2018. https://www.aad.org/public/spot-skin-cancer/learn-about-skin-cancer/prevent. Accessed 19 April 2018.

  261. Tamura D, DiGiovanna JJ, Khan SG, Kraemer KH. Living with xeroderma pigmentosum: comprehensive photoprotection for highly photosensitive patients. Photodermatol Photoimmunol Photomed. 2014;30(2–3):146–52.

    Article  PubMed  CAS  Google Scholar 

  262. Kuwabara A, Tsugawa N, Tanaka K, Uejima Y, Ogawa J, Otao N, et al. High prevalence of vitamin D deficiency in patients with xeroderma pigmetosum-A under strict sun protection. Eur J Clin Nutr. 2015;69(6):693–6.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Henry Ford Hospital, 3031 West Grand Blvd, Suite 800, Detroit, MI, 48202, USA

    Amanda F. Nahhas, David M. Oberlin, Taylor L. Braunberger & Henry W. Lim

Authors
  1. Amanda F. Nahhas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David M. Oberlin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Taylor L. Braunberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Henry W. Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Henry W. Lim.

Ethics declarations

Funding

No funding was received for the preparation of this review.

Conflict of interest

Dr. Lim has served as research investigator for Estee Lauder, Ferndale Laboratories, Allergan, and Incyte Corporation, with grants received by institution. Dr. Nahhas and Dr. Braunberger are sub-investigators for Estee Lauder, Unigen Incorporation, Ferndale Laboratories, and Bayer, with grants received by institution. Dr. Oberlin has no relevant conflicts of interest to declare.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nahhas, A.F., Oberlin, D.M., Braunberger, T.L. et al. Recent Developments in the Diagnosis and Management of Photosensitive Disorders. Am J Clin Dermatol 19, 707–731 (2018). https://doi.org/10.1007/s40257-018-0365-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40257-018-0365-6

Search

Navigation